Imcheck Therapeutics

Developer of immunotherapeutic antibodies for the treatment of multiple diseases

placeMarseille, Provence Alpes Cote D Azur, France calendar_todayFounded 2015 groups48 employees language imchecktherapeutics.com

Social engagement

Social engagement: 11.7K social following, 8 posts in the last 12 months — below the industry typical range.

Investor mix

18 investors on record; lead investors include Pureos Bioventures, Bpifrance, Boehringer Ingelheim Venture Fund, Kurma Partners; 4 have since exited.

Investor typeCountShare
Venture capital633%
Private equity739%
Bank & private debt16%
Other / undisclosed422%

Recent activity

5 Dec 2025
Event
American Society of Hematology Annual Meeting
7 Nov 2025
Event
SITC 2025
3 Sep 2025
Event
SOHO 2025
Coming soon